JOCHEN ZIMMER, UNIVERSITY OF VIRGINIA
The Zimmer lab focuses on complex carbohydrates and how they are synthesized and deposited on the cell surface. Using the tools of structural and molecular biology, they study capsule and biofilm formation in bacteria, cell wall biosynthesis in plants, and extracellular matrix formation in vertebrates.
LYNETTE CEGELSKI, DEPARTMENT OF CHEMISTRY
Attend Dr. Cegelski's pre-seminar presentation to learn more about Dr. Jochen Zimmer's seminar, "Sugary coats: Diverse mechanisms of complex carbohydrate secretion", to be held Thursday, February 14th.
STANLEY QI, DEPARTMENTS OF BIOENGINEERING AND CHEMICAL & SYSTEMS BIOLOGY
Dr. Qi is a pioneer in the CRISPR technology development for genome engineering. His research laboratory focuses on the bioengineering of genetics and cells. They are interested in developing genetic engineering technologies and exploring discovery-based synthetic biology for diverse applications, and explore how the human genome encodes functions, and how to rationally design genetic circuits for new therapeutics.
Dr. Darlene Solomon is senior vice president and chief technology officer for Agilent Technologies. Her responsibilities include Agilent Research Laboratories which focuses on high impact, longer range research in support of Agilent's sustained business growth, and Agilent's programs in university relations, external research and venture investment. In her leadership role, she works closely with Agilent's businesses to define the company's technology strategy and R&D priorities.
BRYAN ROTH, UNIVERSITY OF NORTH CAROLINA
This seminar has been canceled. Please join us for future seminars.
RON DROR, DEPARTMENT OF COMPUTER SCIENCE
Attend Dr. Dror's pre-seminar presentation to learn more about Dr. Bryan Roth's seminar, "Molecular insights into psychoactive drug actions", to be held Thursday, November 15th.
Lisa Giocomo
H. Craig Heller
Dennis Wall
Ravindra Majeti
Peter Santa Maria
Anson Lee
Helen Blau
Paul Wang
Eric Appel
DARIA MOCHLY-ROSEN, DEPARTMENT OF CHEMICAL & SYSTEMS BIOLOGY
Dr. Daria Mochly-Rosen founded the SPARK program to provide a cost-effective model to generate proof of concept using industry standards. Since 2006, SPARK has advanced scores of new diagnostics and drugs to the clinic and commercial sectors and educated hundreds of faculty, postdoctoral fellows, and students on the translational process. Dr. Mochly-Rosen's research lab is a multi-disciplinary lab that includes chemists, biochemists, biologists and physician scientists. They develop pharmacological agents and apply them to understand molecular and cellular events under basal and disease conditions using in vitro, in culture and in vivo models.
